This study examined the use of an actor to communicate prescription drug risks on pharmaceutical websites. Participants viewed risk information for a fictitious drug in one of several static visual formats or as a paragraph plus an animated actor; and with or without a signal directing them to the risk information text. The signal had little effect on outcomes. Format did not affect risk processing, but participants in the actor condition thought the website placed less emphasis on benefits. Actors communicating risk information on a pharmaceutical website do not appear to improve consumers' understanding of prescription drug information.
Actors in whitespace
Communicating risk information on pharmaceutical websites
O'Donoghue, A. C., Sullivan, H. W., Rupert, D. J., Fitts Willoughby, J., & Aikin, K. J. (2019). Actors in whitespace: Communicating risk information on pharmaceutical websites. Health Marketing Quarterly, 36(2), 152-167. https://doi.org/10.1080/07359683.2019.1575063
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article
Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article
The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article